Acute Myeloid Leukemia (AML)

Program Materials

Program Support

Support for this program is provided by Agios, Bristol-Myers Squibb, Daiichi Sankyo, Genentech and Biogen, and Jazz Pharmaceuticals.

Topics Covered

We invite you to learn more about:

• Treatment advances for acute myeloid leukemia (AML)
• How certain genetic mutations can impact your treatment options
• Side-effects management
• Questions you should ask your healthcare team

Speaker

James M. Foran, MD, FRCPC
Associate Professor, Oncology
Chair, Acute Leukemia & Myeloid Neoplasm Disease Group, Mayo Clinic Cancer Center
Associate Chair (Research), Department of Medicine, Mayo Clinic
Jacksonville, FL

Audio Replay

Program Materials

Program Support

Support for this program provided by Agios, Celgene, and Novartis.

< Back to Webcasts

Topics Covered

We invite you to learn more about:

• Current and emerging treatments for acute myeloid leukemia (AML)
• Side-effects management
• Communicating effectively with your healthcare team

Program Materials

Speaker

Rory Shallis, MD
Assistant Professor, Medicine (Hematology)
Yale Cancer Center and
Smilow Cancer Hospital
New Haven, CT
 

Program Support

Support for this program provided by AbbVie Inc. and Genentech, Inc. & Biogen.

< Back to Webcasts

The Leukemia & Lymphoma Society (LLS) and The National Coalition of 100 Black Women, Inc. (NCBW) host an informative webinar about the Impact of Pediatric Leukemia in Black Children. While significant improvements have been made for children with acute lymphoblastic leukemia (ALL) in the U.S., Black patients continue to have inferior outcomes. Join us for an informative panel discussion and Q & A session about the importance of equal access to effective treatments and the potential impact on cure and mortality rates. 

Special Guests

• Rayne H. Rouce, MD, Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
• Courtney Addison, Parent Advocate & Mom and Caregiver of Leukemia Survivor

< Back to Webcasts

Topics Covered

When it comes to online Acute Myeloid Leukemia (AML) resources, how do you separate fact from fiction? During this live webinar, Dr. Jessica Altman shared her expertise on treatments and side effects associated with AML.

 

Speaker

Jessica Altman, MD
Director of Acute Leukemia Program
Robert H. Lurie Comprehensive Cancer Center
Center of Northwestern University

 

Program Support

This webinar is brought to you by the Patient Empowerment Network, in partnership with The Leukemia & Lymphoma Society. We thank Astellas Pharma US, Inc., Celgene Corporation and Daiichi Sankyo for their support.

< Back to Webcasts

Topics Covered

We invite you to learn more about:

• Understanding the emotional and psychological effects of AML
• Healthy ways to cope with feelings of fear, anxiety and stress
• Novel agents in development for AML
• Advice for patients seeking clinical trials

Speakers

Beth Kart Probert
Patient Advocate and Host

Thomas LeBlanc, MD
Medical Oncologist
Duke Cancer Institute

Michelle Rajotte, LMSW
Associate Director of the Information Resource Center
The Leukemia & Lymphoma Society (LLS)

James (Jim) Bond
AML and Myeloma Survivor and Patient Advocate

Program Support

Support for this program provided by The Leukemia & Lymphoma Society, Patient Empowerment Network, and Patient Power.

< Back to Webcasts